Objective: The global aging population has led to a significant increase in hip fractures among elderly patients, posing substantial clinical challenges. While early surgical intervention is widely advocated, its impact on postoperative complications and mortality in super-aged (≥ 80 years) hip fracture patients remains controversial. This study aimed to evaluate the association between early surgery and clinical outcomes in this population.
Methods: We conducted a retrospective cohort study of patients aged ≥ 80 years who underwent hip fracture surgery at a single-center orthopedic trauma center between January 2018 and November 2021. Participants were stratified into early surgery (≤ 48 h post-admission) and non-early surgery groups. Propensity score matching (PSM) was employed to control for confounding variables. Primary outcomes included 30-day, 90-day, 1-year, and 2-year mortality rates. Secondary outcomes encompassed perioperative transfusion rates, postoperative complications, hospital length of stay (LOS), and hospitalization costs.
Results: After PSM, a total of 300 patients were included. Compared with the non-early surgery group, the early surgery group had lower 1-year (11.6% vs. 28.0%, p < 0.001) and 2-year (36.0% vs. 50.7%, p = 0.010) postoperative mortality rates, a lower perioperative blood transfusion rate (32.7% vs. 53.3%, p < 0.001), lower incidences of postoperative pneumonia (15.3% vs. 29.3%, p = 0.004) and delirium (14.0% vs. 36.0%, p < 0.001), a shorter length of stay [8.6 days (7.5, 11.2) vs. 11.6 days (9.7, 14.9), p < 0.001], and lower hospitalization expenses [54,336 ¥ (48,965, 64,532) vs. 61,616 ¥ (50,758, 74,484), p = 0.001]. The serum albumin level at discharge in the early surgery group was higher (33.4 (31.6, 35.4) vs. 32.6 (30.7, 34.9), p = 0.039). Kaplan–Meier survival curve analysis showed that the all-cause mortality rate in the non-early surgery group increased (Log Rank p = 0.0066). Multivariate Cox analysis showed that age, BMI, admission hemoglobin, and non-early surgery were risk factors for 2-year mortality.
Conclusion: Early surgical intervention for hip fractures in super-aged patients is associated with improved survival, reduced complications, and better resource utilization. These findings support the implementation of protocols to minimize preoperative delays in this vulnerable population.
| [1] |
Y. Rolland, G. van Abellan Kan, A. Bénétos, et al., “Frailty, Osteoporosis and Hip Fracture: Causes, Consequences and Therapeutic Perspectives,” Journal of Nutrition, Health & Aging 12 (2008): 335–346.
|
| [2] |
B. Y. Xu, S. Yan, L. L. Low, F. F. Vasanwala, and S. G. Low, “Predictors of Poor Functional Outcomes and Mortality in Patients With Hip Fracture: A Systematic Review,” BMC Musculoskeletal Disorders 20 (2019): 568.
|
| [3] |
C. Cooper, G. Campion, and L. J. Melton, “Hip Fractures in the Elderly: A World-Wide Projection,” Osteoporosis International 2 (1992): 285–289.
|
| [4] |
P. Tewari, B. F. Sweeney, J. L. Lemos, et al., “Evaluation of Systemwide Improvement Programs to Optimize Time to Surgery for Patients With Hip Fractures: A Systematic Review,” JAMA Network Open 5 (2022): e2231911.
|
| [5] |
S. Cui, L. Zhao, W. Zhao, et al., “Excess Mortality for Femoral Intertrochanteric Fracture Patients Aged 50 Years and Older Treated Surgically and Conservatively in Tianjin, China: A Cohort Study,” Orthopaedic Surgery 16 (2024): 207–215.
|
| [6] |
S. A. I. Loggers, E. M. M. Van Lieshout, P. Joosse, M. H. J. Verhofstad, and H. C. Willems, “Prognosis of Nonoperative Treatment in Elderly Patients With a Hip Fracture: A Systematic Review and Meta-Analysis,” Injury 51 (2020): 2407–2413.
|
| [7] |
R. Jain, A. Basinski, and H. J. Kreder, “Nonoperative Treatment of Hip Fractures,” International Orthopaedics 27 (2003): 11–17.
|
| [8] |
H. Fischer, T. Maleitzke, C. Eder, S. Ahmad, U. Stöckle, and K. F. Braun, “Management of Proximal Femur Fractures in the Elderly: Current Concepts and Treatment Options,” European Journal of Medical Research 26 (2021): 86.
|
| [9] |
D. Saul, J. Riekenberg, J. C. Ammon, D. B. Hoffmann, and S. Sehmisch, “Hip Fractures: Therapy, Timing, and Complication Spectrum,” Orthopaedic Surgery 11 (2019): 994–1002.
|
| [10] |
C. Tian, H. Zhu, L. Shi, X. Chen, T. Xie, and Y. Rui, “Is There a “Black Friday” for Geriatric Hip Fracture Surgery?,” Orthopaedic Surgery 15 (2023): 1304–1311.
|
| [11] |
B. A. Pech-Ciau, E. A. Lima-Martínez, G. A. Espinosa-Cruz, C. R. Pacho-Aguilar, O. Huchim-Lara, and R. A. Alejos-Gómez, “Hip Fracture in the Elderly: Epidemiology and Costs of Care,” Acta Ortopédica Mexicana 35 (2021): 341–347.
|
| [12] |
F. J. Amarilla-Donoso, F. López-Espuela, R. Roncero-Martín, et al., “Quality of Life in Elderly People After a Hip Fracture: A Prospective Study,” Health and Quality of Life Outcomes 18 (2020): 71.
|
| [13] |
S. M. Friedman and D. A. Mendelson, “Epidemiology of Fragility Fractures,” Clinics in Geriatric Medicine 30 (2014): 175–181.
|
| [14] |
R. Menéndez-Colino, A. Gutiérrez Misis, T. Alarcon, et al., “Development of a New Comprehensive Preoperative Risk Score for Predicting 1-Year Mortality in Patients With Hip Fracture: The HULP-HF Score. Comparison With 3 Other Risk Prediction Models,” Hip International 31 (2021): 804–811.
|
| [15] |
N. Veronese and S. Maggi, “Epidemiology and Social Costs of Hip Fracture,” Injury 49 (2018): 1458–1460.
|
| [16] |
S. Katsanos, S. Sioutis, L. Reppas, et al., “What Do Hip Fracture Patients Die From?,” European Journal of Orthopaedic Surgery and Traumatology 33 (2023): 751–757.
|
| [17] |
A. M. Nyholm, K. Gromov, H. Palm, et al., “Time to Surgery Is Associated With Thirty-Day and Ninety-Day Mortality After Proximal Femoral Fracture: A Retrospective Observational Study on Prospectively Collected Data From the Danish Fracture Database Collaborators,” JBJS 97 (2015): 1333.
|
| [18] |
N. Simunovic, P. J. Devereaux, S. Sprague, et al., “Effect of Early Surgery After Hip Fracture on Mortality and Complications: Systematic Review and Meta-Analysis,” CMAJ 182 (2010): 1609–1616.
|
| [19] |
D. Pincus, B. Ravi, D. Wasserstein, et al., “Association Between Wait Time and 30-Day Mortality in Adults Undergoing Hip Fracture Surgery,” JAMA 318 (2017): 1994–2003.
|
| [20] |
C. P. Bretherton and M. J. Parker, “Early Surgery for Patients With a Fracture of the Hip Decreases 30-Day Mortality,” Bone and Joint Journals 97-B (2015): 104–108.
|
| [21] |
S. C. Castellanos, F. L. Marco, E. B. Domínguez, E. M. V. Gálvez, and B. M. Pérez, “Does Delaying Surgery for ‘Healthy’ Hip Fracture Patients Have Increased Complications and Mortality?,” Injury 53 (2022): 3209–3213.
|
| [22] |
M. K. Ng, J. B. Pasternack, P. G. Mastrokostas, L. Voyvodic, and K. K. Kang, “The Real Time to Surgery: Limited Delay After Medical Optimization Does Not Impact Hip Fracture Surgery Outcomes,” Injury 55 (2024): 111421.
|
| [23] |
A. Lizaur-Utrilla, D. Martinez-Mendez, I. Collados-Maestre, F. A. Miralles-Muñoz, L. Marco-Gomez, and F. A. Lopez-Prats, “Early Surgery Within 2 Days for Hip Fracture Is Not Reliable as Healthcare Quality Indicator,” Injury 47 (2016): 1530–1535.
|
| [24] |
J. Guo, B. Zhang, H. Yu, et al., “Propensity Score Matching Analysis of Early vs. Delayed Surgery for Intertrochanteric Fracture in Older Patients: A Retrospective Multicenter Cohort Study of 7414 Patients With a Mean 4-Year Follow Up,” BMC Geriatrics 24 (2024): 821.
|
| [25] |
C. Wulbrand, B. Füchtmeier, M. Weber, C. Eckstein, A. Hanke, and F. Müller, “Surgery Within 24 Hours Reduces Mortality and General Complication Rates in Patients Who Have Periprosthetic Femoral Fractures at the Hip,” Journal of Arthroplasty 39 (2024): 2104–2110.e1.
|
| [26] |
D. De Mauro, G. Capece, M. Covino, et al., “Periprosthetic Femur Fractures of the Hip in Elderly Patients: Early Surgery Reduces Operative Time, Hospitalization, and Mortality,” European Journal of Orthopaedic Surgery & Traumatology 35 (2025): 255.
|
| [27] |
Y. Rui, X. Qiu, J. Zou, et al., “Clinical Application of Multidisciplinary Team Co-Management in Geriatric Hip Fractures,” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 33 (2019): 1276–1282.
|
| [28] |
A. Kristan, S. Omahen, T. H. Tosounidis, and M. Cimerman, “When Does Hip Fracture Surgery Delay Affects the Length of Hospital Stay?,” European Journal of Trauma and Emergency Surgery 48 (2022): 701–708.
|
| [29] |
E. S. Siris, R. Adler, J. Bilezikian, et al., “The Clinical Diagnosis of Osteoporosis: A Position Statement From the National Bone Health Alliance Working Group,” Osteoporosis International 25 (2014): 1439–1443.
|
| [30] |
M. Tohidi, G. Grammatopoulos, S. M. Mann, et al., “Patient Factors Associated With 10-Year Survival After Arthroplasty for Hip Fracture: A Population-Based Study in Ontario, Canada,” Journal of Bone and Joint Surgery. American Volume 106 (2024): 2073–2084.
|
| [31] |
T. Smith, K. Pelpola, M. Ball, A. Ong, and P. K. Myint, “Pre-Operative Indicators for Mortality Following Hip Fracture Surgery: A Systematic Review and Meta-Analysis,” Age and Ageing 43 (2014): 464–471.
|
| [32] |
K. A. Espinosa, A. G. Gélvez, L. P. Torres, M. F. García, and O. R. Peña, “Pre-Operative Factors Associated With Increased Mortality in Elderly Patients With a Hip Fracture: A Cohort Study in a Developing Country,” Injury 49 (2018): 1162–1168.
|
| [33] |
M. Bhandari and M. Swiontkowski, “Management of Acute Hip Fracture,” New England Journal of Medicine 377 (2017): 2053–2062.
|
| [34] |
M. M. Iqbal, “Osteoporosis: Epidemiology, Diagnosis, and Treatment,” Southern Medical Journal 93 (2000): 2–18.
|
| [35] |
GBD 2019 Fracture Collaborators, “Global, Regional, and National Burden of Bone Fractures in 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019,” Lancet Healthy Longevity 2 (2021): e580–e592.
|
| [36] |
J. A. Switzer and M. I. O'Connor, “AAOS Management of Hip Fractures in Older Adults Evidence-Based Clinical Practice Guideline,” Journal of the American Academy of Orthopaedic Surgeons 30 (2022): e1297–e1301.
|
| [37] |
M. Chen, Y. Du, W. Tang, et al., “Risk Factors of Mortality and Second Fracture After Elderly Hip Fracture Surgery in Shanghai, China,” Journal of Bone and Mineral Metabolism 40 (2022): 951–959.
|
| [38] |
K. Maheshwari, J. Planchard, J. You, et al., “Early Surgery Confers 1-Year Mortality Benefit in Hip-Fracture Patients,” Journal of Orthopaedic Trauma 32 (2018): 105–110.
|
| [39] |
P. Colais, M. Di Martino, D. Fusco, et al., “The Effect of Early Surgery After Hip Fracture on 1-Year Mortality,” BMC Geriatrics 15 (2015): 141.
|
| [40] |
A. M. Lawless, S. Narula, P. D'Alessandro, C. W. Jones, H. Seymour, and P. J. Yates, “Time to Surgery and Transfer-Associated Mortality for Hip Fractures in Western Australia,” ANZ Journal of Surgery 90 (2020): 1750–1753.
|
| [41] |
A. Lizaur-Utrilla, B. Gonzalez-Navarro, M. F. Vizcaya-Moreno, F. A. Miralles Muñoz, S. Gonzalez-Parreño, and F. A. Lopez-Prats, “Reasons for Delaying Surgery Following Hip Fractures and Its Impact on One Year Mortality,” International Orthopaedics 43 (2019): 441–448.
|
| [42] |
E. Noll, L. Keller, P. Tran Ba Loc, et al., “Effect of Surgical Delay on 30-Day Mortality in Patients Receiving Direct Oral Anticoagulants and Admitted for Hip Fracture,” Injury 54 (2023): 110813.
|
| [43] |
L. A. Beaupre, H. Khong, C. Smith, et al., “The Impact of Time to Surgery After Hip Fracture on Mortality at 30- and 90-Days: Does a Single Benchmark Apply to All?,” Injury 50 (2019): 950–955.
|
| [44] |
J. Y. Yoon, S. Kim, J. S. Chang, P. W. Yoon, and J. W. Kim, “Venous Thromboembolism After Delayed Surgery for a Hip Fracture: A Retrospective Cohort Study,” Geriatrics & Gerontology International 20 (2020): 1151–1156.
|
| [45] |
A. B. Pedersen, V. Ehrenstein, S. K. Szépligeti, et al., “Excess Risk of Venous Thromboembolism in Hip Fracture Patients and the Prognostic Impact of Comorbidity,” Osteoporosis International 28 (2017): 3421–3430.
|
| [46] |
Y.-M. Qi, Y.-J. Li, J.-H. Zou, et al., “Risk Factors for Postoperative Delirium in Geriatric Patients With Hip Fracture: A Systematic Review and Meta-Analysis,” Frontiers in Aging Neuroscience 14 (2022): 960364.
|
| [47] |
A. A. Sayer and A. Cruz-Jentoft, “Sarcopenia Definition, Diagnosis and Treatment: Consensus Is Growing,” Age and Ageing 51 (2022): afac220.
|
| [48] |
N. E. Lane, “Epidemiology, Etiology, and Diagnosis of Osteoporosis,” American Journal of Obstetrics and Gynecology 194 (2006): S3–S11.
|
| [49] |
T.-I. Yang, Y.-H. Chen, M.-H. Chiang, Y.-J. Kuo, and Y.-P. Chen, “Inverse Relation of Body Weight With Short-Term and Long-Term Mortality Following Hip Fracture Surgery: A Meta-Analysis,” Journal of Orthopaedic Surgery and Research 17 (2022): 249.
|
| [50] |
C. Rui, G. Dai, C. Tian, et al., “Anti-Inflammatory Effect of Multi-Dose Tranexamic Acid in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,” Inflammopharmacology 33 (2025): 917–928.
|
| [51] |
M. Hedström, O. Ljungqvist, and T. Cederholm, “Metabolism and Catabolism in Hip Fracture Patients: Nutritional and Anabolic Intervention: A Review,” Acta Orthopaedica 77 (2006): 741–747.
|
| [52] |
X. Hébuterne, S. Bermon, and S. M. Schneider, “Ageing and Muscle: The Effects of Malnutrition, Re-Nutrition, and Physical Exercise,” Current Opinion in Clinical Nutrition and Metabolic Care 4 (2001): 295–300.
|
| [53] |
J. C. Yombi, D. C. Putineanu, O. Cornu, P. Lavand’homme, P. Cornette, and D. Castanares-Zapatero, “Low Haemoglobin at Admission Is Associated With Mortality After Hip Fractures in Elderly Patients,” Bone & Joint Journal 101-B (2019): 1122–1128.
|
| [54] |
N. B. Foss, M. T. Kristensen, and H. Kehlet, “Anaemia Impedes Functional Mobility After Hip Fracture Surgery,” Age and Ageing 37 (2008): 173–178.
|
| [55] |
B.-F. Zhang, S.-L. Xu, Z. Yang, and P. Xu, “Early Admission Is Better–the Time to Admission (TTA) is Associated With One-Year Mortality in Hip Fracture,” International Journal of Surgery 110 (2024): 7880.
|
| [56] |
Y. Jiang, S. Tan, K. Qin, et al., “Impact of Prehospital Delay on Postoperative Complications and 5-Year Mortality in Older Adults With Hip Fractures,” Injury 56 (2025): 112727.
|
RIGHTS & PERMISSIONS
2026 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.